UBS’s Apyx Medical APYX Stock Holding History

UBS’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$12K	Hold	3,000	–	–	﹤0.01%	8612
2014 Q2	$11K	Hold	3,000	–	–	﹤0.01%	8760
2014 Q1	$12K	Hold	3,000	–	–	﹤0.01%	8673
2013 Q4	$6K	Sell	3,000 -1,121	-27%	-$2.73K	﹤0.01%	9405
2013 Q3	$11K	Buy	4,121 +1,121	+37%	+$3.43K	﹤0.01%	8705
2013 Q2	$9K	Buy	+3,000	New	+$10.1K	﹤0.01%	8708

Other funds holding APYX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MIAN

Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's APYX Position: Q3 2014 in Review

UBS held its Apyx Medical (APYX) position steady in Q3 2014 at 3,000 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #8612.

UBS first reported a position in APYX in Q2 2013 and has held it in 6 quarters since. 20 funds tracked by Wall St. Rank hold APYX as of Q3 2014.

UBS held 3,000 shares of Apyx Medical worth $12K as of Q3 2014.
UBS left its Apyx Medical share count unchanged in Q3 2014.
Apyx Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8612 holding.
UBS first reported a position in Apyx Medical in Q2 2013 and has held it in 6 quarters since.
20 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.